Interdisciplinary NexGen TB research Advancement Center (IN-TRAC)
Interdisciplinary NexGen TB research Advancement Center (IN-TRAC)
批准号:
10431465
负责人:
Larry S. Schlesinger
金额:
$119.94万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-03-10 至 2027-02-28
关键词:
AddressAnimal ModelAnimalsBiomedical ResearchChestCitiesClinicClinicalClinical ManagementClinical ResearchClinical ServicesCommunicable DiseasesCommunicationCommunitiesCommunity HealthcareComplementComprehensionConfocal MicroscopyCountryCytometryDevelopmentDisciplineDisease ManagementEducational CurriculumEnsureFundingFunding AgencyGrantHealthHealth ProfessionalHospitalsIACUCImageIndividualIndustryInpatientsInstitutesInterdisciplinary StudyInternshipsKnowledgeLeadershipLearningMechanicsMexicoMissionMusNational Institute of Allergy and Infectious DiseaseOutpatientsPET/CT scanParticipantPatient CarePreventionProceduresProtocols documentationResearchResearch InstituteResearch PersonnelResourcesRisk AssessmentRodentScienceScientistSiteTexasTrainingTraining ProgramsTuberculosisUnited States National Institutes of HealthUniversitiesWorkWritingbiocontainment facilitycareer developmentcellular imagingcohortcommercializationexperienceexternshiplive cell imagingmetropolitanmultidisciplinarynext generationnonhuman primateorganizational structurepeerpoint of carepreventprogramsprospectivesingle-cell RNA sequencingskillssuccesstoolwhole body imaging
中文摘要
点击翻译按钮获取中文摘要
英文摘要
TEXAS BIOMED IN-TRAC OVERALL ABSTRACT
The Interdisciplinary NexGen TB Research Advancement Center (IN-TRAC) at Texas Biomedical Research
Institute (Texas Biomed) will attract the next generation of diverse researchers to the tuberculosis (TB) research
field, and develop them into independent researchers with multi-disciplinary skills and real-world experience of
clinical TB. The product of IN-TRAC will be researchers that choose to work on some of the most challenging
and relevant translational problems in TB, and that work across academic disciplines and within a framework of
highly collaborative research. This will be achieved through 6 interrelated Cores. Administrative Core: The
central hub of IN-TRAC management and oversight, with responsibility for administrative and scientific
leadership; coordinating communication between Cores, researchers and NIH/NIAID Program staff and
providing an organizational structure to optimize multidisciplinary collaborations and interactions between the
Cores and among a diverse cohort of IN-TRAC participants. Development Core: Oversight of all career
development programming and courses, tailoring the research and clinical experiences, both intern and
externships, to each individual IN-TRAC participant, and management of the IN-TRAC pilot grant program.
Biosafety & Biocontainment Core: Extending the required biosafety training to a personalized curriculum
including theoretical and hands-on biocontainment training, understanding the mechanical and regulatory
requirements of a BSL3/ABSL3, coaching on how to develop biosafety protocols, and working through risk
assessments from the perspective of a Biosafety Officer. Research Imaging Core: Providing theoretical and
hands-on training from single cell imaging (confocal microscopy, cytometry, live cell imaging, single cell RNAseq)
through to whole body imaging in mice (IVIS) and Non-human primates (NHP) (PET/CT) within large, fully
outfitted BSL3/ABSL3 facilities. Animal Model Core: Implementing a training program to introduce all IN-TRAC
participants to the regulatory requirements for working with rodents and NHPs, how to develop a robust
experimental protocol, how to write an IACUC protocol, and hands-on animal handling and experimental
procedures. Clinical Research & Patient Care Core: Introducing IN-TRAC participants to TB patient care at
the only free-standing TB hospital in the US (Texas Center of Infectious Diseases) that manages some of the
most challenging cases of TB nationally. Partnering with this will be a clinical research experience at the US-
Mexico border, to experience TB studies in under-served and under-resourced communities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:10431466
-
项目类别:
-
资助金额:$19.99万
-
财政年份:2022
-
负责人:Larry S. Schlesinger
-
依托单位:
Interdisciplinary NexGen TB research Advancement Center (IN-TRAC)
-
批准号:10588203
-
项目类别:
-
资助金额:$115.01万
-
财政年份:2022
-
负责人:Larry S. Schlesinger
-
依托单位:
Clinical Research & Patient Care Core (CRPCC)
-
批准号:10431471
-
项目类别:
-
资助金额:$19.99万
-
财政年份:2022
-
负责人:Larry S. Schlesinger
-
依托单位:
Administrative Core
-
批准号:10588204
-
项目类别:
-
资助金额:$8.61万
-
财政年份:2022
-
负责人:Larry S. Schlesinger
-
依托单位:
Clinical Research & Patient Care Core (CRPCC)
-
批准号:10588232
-
项目类别:
-
资助金额:$12.83万
-
财政年份:2022
-
负责人:Larry S. Schlesinger
-
依托单位:
Macrophage nuclear receptors, metabolism and immune effectors during health and M. tuberculosis infection
-
批准号:10450960
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Larry S. Schlesinger
-
依托单位:
Macrophage nuclear receptors, metabolism and immune effectors during health and M. tuberculosis infection
-
批准号:10457308
-
项目类别:
-
资助金额:$70.68万
-
财政年份:2019
-
负责人:Larry S. Schlesinger
-
依托单位:
Macrophage nuclear receptors, metabolism and immune effectors during health and M. tuberculosis infection- Diversity Supplement
-
批准号:10116937
-
项目类别:
-
资助金额:$3.46万
-
财政年份:2019
-
负责人:Larry S. Schlesinger
-
依托单位:
Expansion of Marmoset Breeding Facilities to Meet Increasing Research Demands
-
批准号:9933536
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2019
-
负责人:Larry S. Schlesinger
-
依托单位:
Macrophage nuclear receptors, metabolism and immune effectors during health and M. tuberculosis infection
-
批准号:10215474
-
项目类别:
-
资助金额:$70.68万
-
财政年份:2019
-
负责人:Larry S. Schlesinger
-
依托单位:
Host bacterial targets mediating immune suppression in pneumonic tularemia
-
批准号:8448670
-
项目类别:
-
资助金额:$60.84万
-
财政年份:2013
-
负责人:Larry S. Schlesinger
-
依托单位:
TB and Innate Immune Regulation of Lung Macrophages
-
批准号:8499656
-
项目类别:
-
资助金额:$6.45万
-
财政年份:2012
-
负责人:Larry S. Schlesinger
-
依托单位:
Host bacterial targets mediating immune suppression in pneumonic tularemia
-
批准号:8233341
-
项目类别:
-
资助金额:$60.46万
-
财政年份:2011
-
负责人:Larry S. Schlesinger
-
依托单位:
Medical Scientist Training Program - Ohio State University
-
批准号:8501526
-
项目类别:
-
资助金额:$29.79万
-
财政年份:2011
-
负责人:Larry S. Schlesinger
-
依托单位:
Medical Scientist Training Program - Ohio State University
-
批准号:8689090
-
项目类别:
-
资助金额:$30.08万
-
财政年份:2011
-
负责人:Larry S. Schlesinger
-
依托单位:
Medical Scientist Training Program - Ohio State University
-
批准号:8078747
-
项目类别:
-
资助金额:$9.84万
-
财政年份:2011
-
负责人:Larry S. Schlesinger
-
依托单位:
Medical Scientist Training Program - Ohio State University
-
批准号:8278528
-
项目类别:
-
资助金额:$19.86万
-
财政年份:2011
-
负责人:Larry S. Schlesinger
-
依托单位:
Medical Scientist Training Program - Ohio State University
-
批准号:8878287
-
项目类别:
-
资助金额:$19.55万
-
财政年份:2011
-
负责人:Larry S. Schlesinger
-
依托单位:
Acquisition of a MALDI-TOF/TOF MS for Glycomic and Lipidomic Research
-
批准号:7794367
-
项目类别:
-
资助金额:$41.5万
-
财政年份:2010
-
负责人:Larry S. Schlesinger
-
依托单位:
Host bacterial targets mediating immune suppression in pneumonic tularemia
-
批准号:7672070
-
项目类别:
-
资助金额:$54.59万
-
财政年份:2009
-
负责人:Larry S. Schlesinger
-
依托单位:
海外基金